Continuous Fc detection for protein A capture process control

Biosens Bioelectron. 2020 Oct 1:165:112327. doi: 10.1016/j.bios.2020.112327. Epub 2020 May 29.

Abstract

Purification of therapeutic monoclonal antibodies usually involves a protein A affinity capture step. Because column breakthrough of antibody in complex, UV-absorbing culture fluid cannot be readily detected in real time, processes are designed so conservatively that column capacity is usually underutilized, wasting adsorbent and reducing productivity. We have developed a fluorescence-based monitoring technology which allows real-time mAb monitoring and used it to detect IgG in column breakthrough. The column effluent was continuously contacted with soluble fluorescein-labeled Fc-binding ligands to produce an immediately-detectable shift in both fluorescence polarization and intensity. To extend the upper limit of inlet flow rate, a 14:1 split-ratio flow splitter was tested with an inlet flow of 15 mL/min (0.9 L/h), producing a sampling stream at 1 mL/min while still enabling continuous detection functionality. We observed significant shifts in fluorescence intensity in CHO cell culture fluid spiked with human IgG, and detected 0.02-0.1 g/L human IgG in protein A column breakthrough at a flow velocity of 80 cm/h. The increase in fluorescence intensity upon 0.1% breakthrough of an 1 g/L feed was used to trigger column switching using Python-enabled two-way communication with the standard Unicorn OPC process control protocol. The technology allows rapid, continuous and reliable monitoring of IgG in a flowing process stream, without elaborate sample preparation.

Keywords: Antibody breakthrough; Fluorescence intensity; Fluorescence polarization; Process analytical technology; Protein A chromatography; Real-time monitoring.

MeSH terms

  • Animals
  • Biosensing Techniques*
  • CHO Cells
  • Chromatography, Affinity
  • Cricetinae
  • Cricetulus
  • Humans
  • Staphylococcal Protein A*

Substances

  • Staphylococcal Protein A